Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
July 09, 2025
Global Recognition! International Publication of Phase I Hepatology Clinical Trial
Global Recognition
International Publication of Phase I Hepatology Clinical Trial
Manuscript Accepted In: Advances in Pharmacological and Pharmaceutical Sciences
Publisher: Wiley
Impact Factor: 2.1
Acceptance Rate: ~21%
Indexed In:
PubMed (NLM)
SCOPUS (Elsevier)
Web of Science (Clarivate Analytics)
Embase (Elsevier)
Directory of Open Access Journals (DOAJ)
CBCC Global Research: Benchmarked to Global Standards of Excellence!
Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas
ClinicalResearch PharmaceuticalScience Hepatology DrugDevelopment
ClinicalTrials PhaseITrial MedicalResearch
